Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Luminex respiratory panel cleared

This article was originally published in The Gray Sheet

Executive Summary

Toronto-based Luminex Molecular Diagnostics Jan. 3 obtains 510(k) clearance and launches its xTAG Respiratory Viral Panel, which detects 12 viruses and subtypes that are responsible for more than 85% of respiratory viral infections. xTAG RVP yields results in 10 hours and is the first test for detecting and differentiating influenza A subtypes H1 and H3, and for detecting human metapneumovirus. The test also detects influenza B; respiratory syncytial virus A and B; andenovirus; parainfluenza 1, 2 and 3; and rhinovirus
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT025629

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel